4,4'-propylenebis(piperazine-2,6-dione)
CAS: 21416-67-1
Ref. 3D-FP156423
10mg | Descontinuado | ||
25mg | Descontinuado | ||
50mg | Descontinuado |
Informação sobre produto
- (±)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane
- (±)-1,2-Bis(3,5-dioxopiperazinyl)propane
- 1,2-Bis(3,5-dioxo-1-piperazinyl)propane
- 2,6-Piperazinedione, 4,4'-(1-Methyl-1,2-Ethanediyl)Bis-
- 2,6-Piperazinedione, 4,4′-propylenedi-
- 21416-67-1
- 4,4'-Propane-1,2-diyldipiperazine-2,6-dione
- 4,4'-Propane-1,3-Diyldipiperazine-2,6-Dione
- 4,4'-Propylenebis(Piperazine-2,6-Dione)
- 4,4′-(1-Methyl-1,2-ethanediyl)bis[2,6-piperazinedione]
- Ver mais sinónimos
- 4,4′-Propylenebis(2,6-piperazinedione)
- 4,4′-Propylenedi(2,6-piperazinedione)
- Ici 59118
- Icrf 159
- NSC 129943
- Razoxin
- Tepirone
- Troxozone
4,4'-propylenebis(piperazine-2,6-dione) is a cytotoxic agent that inhibits the proliferation of cancer cells by interfering with cellular functions. This drug is a monoclonal antibody that binds to receptors found on the surface of tumor cells and blocks the formation of new blood vessels. The antiangiogenic properties of 4,4'-propylenebis(piperazine-2,6-dione) have been shown in animal models. This drug has minimal toxicity and can be used for both in vitro and in vivo studies.